Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia

Medical technologies guidance
Reference number: MTG49
Published: 24 June 2020

Register as a stakeholder

History

Documents created during the development process.

Guidance published

Consultation document (PDF 969 KB)

Published:

22 September 2020
Correspondence with EAC (PDF 630 KB)

Published:

22 September 2020
Equality impact assessment (PDF 146 KB)

Published:

22 September 2020
EAQ Collated Responses (MSWord 96 KB)

Published:

18 April 2023
Clinical expert advice Patient input (MSWord 168 KB)

Published:

18 April 2023
Assessment report (PDF 2.1 MB)

Published:

18 April 2023

Draft guidance

Scope published

Equality impact assessment (PDF 127 KB)

Published:

09 July 2019
Final scope (PDF 223 KB)

Published:

09 July 2019